Literature DB >> 31505195

Hesperidin ameliorates pancreatic β-cell dysfunction and apoptosis in streptozotocin-induced diabetic rat model.

Wanthanee Hanchang1, Aree Khamchan2, Navinee Wongmanee2, Chananchida Seedadee2.   

Abstract

AIMS: The current study was conducted to investigate the potential protective effects of hesperidin and its possible mechanisms of action on pancreatic β-cells in diabetes. MAIN
METHODS: Male Sprague Dawley rats were made diabetic using 65 mg/kg intraperitoneal injection of streptozotocin, and then administered daily with 100 mg/kg of hesperidin over 4 weeks. On conclusion of the experiment, blood and pancreatic tissue were collected to determine the function of β-cells, apoptosis, oxidative stress, ER stress, and inflammation. KEY
FINDINGS: Treatment of diabetic rats with hesperidin, significantly decreased fasting blood glucose and food intake, along with increased body weight, serum and pancreatic insulin levels, and pancreatic-duodenal homeobox-1 (PDX-1) protein expression. The beneficial roles of hesperidin on diabetic pancreatic β-cells exhibited an increment in antioxidant SOD and GPx activities, and a decrement in nitrotyrosine as well as malondialdehyde (MDA) levels. Additionally, the elevated concentration of TNF-α and expressions of ER stress maker GRP78 and CHOP proteins in the pancreas of diabetic rats were significantly diminished by hesperidin treatment. Furthermore, hesperidin effectively modulated expressions of apoptosis-regulatory proteins in diabetic rat pancreas, as revealed by upregulating anti-apoptotic Bcl-xL; with a concomitant downregulating pro-apoptotic Bax, cleaved caspase-3, and inhibiting the activation of DNA repair protein poly (ADP-ribose) polymerase (PARP). SIGNIFICANCE: Collectively, these findings suggest that hesperidin may have the potential to protect pancreatic β-cells and improve their function by suppressing oxidative and ER stress, along with activating its antioxidant, anti-inflammatory, and anti-apoptotic effects.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; ER stress; Hesperidin; Oxidative stress; Pancreatic β-cell

Mesh:

Substances:

Year:  2019        PMID: 31505195     DOI: 10.1016/j.lfs.2019.116858

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Nicotinamide-cinnamic acid cocktail exerts pancreatic β-cells survival coupled with insulin secretion through ERK1/2 signaling pathway in an animal model of apoptosis.

Authors:  Syed Ali Raza Shah; M Israr Khan; Hira Jawaid; Urooj Qureshi; Zaheer Ul-Haq; M Rahman Hafizur
Journal:  Daru       Date:  2021-09-08       Impact factor: 4.088

2.  Exploiting Citrus aurantium seeds and their secondary metabolites in the management of Alzheimer disease.

Authors:  Doha H Abou Baker; Bassant M M Ibrahim; Nabila S Hassan; A F Yousuf; Souad El Gengaihi
Journal:  Toxicol Rep       Date:  2020-06-05

Review 3.  Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.

Authors:  Anna Mas-Capdevila; Joan Teichenne; Cristina Domenech-Coca; Antoni Caimari; Josep M Del Bas; Xavier Escoté; Anna Crescenti
Journal:  Nutrients       Date:  2020-05-20       Impact factor: 5.717

4.  Oral intake of α‑glucosyl‑hesperidin ameliorates selenite‑induced cataract formation.

Authors:  Yosuke Nakazawa; Miki Aoki; Sho Ishiwa; Naoki Morishita; Shin Endo; Noriaki Nagai; Naoki Yamamoto; Megumi Funakoshi-Tago; Hiroomi Tamura
Journal:  Mol Med Rep       Date:  2020-01-14       Impact factor: 2.952

5.  Hesperidin ameliorates liver ischemia/reperfusion injury via activation of the Akt pathway.

Authors:  Shilai Li; Quanlin Qin; Daqing Luo; Wenhui Pan; Yuqing Wei; Yansong Xu; Jijin Zhu; Liming Shang
Journal:  Mol Med Rep       Date:  2020-10-06       Impact factor: 2.952

Review 6.  A Review on Antidiabetic Activity of Centaurea spp.: A New Approach for Developing Herbal Remedies.

Authors:  Samaneh Fattaheian-Dehkordi; Reza Hojjatifard; Mina Saeedi; Mahnaz Khanavi
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-05       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.